VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 703 filers reported holding VANECK VECTORS ETF TR in Q2 2022. The put-call ratio across all filers is 0.58 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,358,285 | -18.1% | 87,636 | -8.4% | 0.14% | -40.7% |
| Q2 2023 | $2,880,473 | +98.7% | 95,665 | +113.4% | 0.24% | +92.9% |
| Q1 2023 | $1,449,992 | +534.6% | 44,822 | +462.2% | 0.13% | +472.7% |
| Q4 2022 | $228,506 | -4.0% | 7,973 | +28.6% | 0.02% | -15.4% |
| Q1 2022 | $238,000 | -20.1% | 6,199 | -38.7% | 0.03% | -29.7% |
| Q3 2021 | $298,000 | -50.6% | 10,109 | -43.0% | 0.04% | -51.9% |
| Q2 2021 | $603,000 | +42.6% | 17,738 | +36.3% | 0.08% | +24.2% |
| Q1 2021 | $423,000 | -10.8% | 13,013 | -1.2% | 0.06% | -17.3% |
| Q4 2020 | $474,000 | +131.2% | 13,174 | +150.9% | 0.08% | +50.0% |
| Q3 2020 | $205,000 | -56.7% | 5,250 | +183.8% | 0.05% | +163.2% |
| Q2 2019 | $473,000 | – | 1,850 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 738,500 | $20,220,000 | 66.82% |
| Baymount Management LP | 145,000 | $3,970,000 | 28.08% |
| New Harbor Financial Group, LLC | 1,371,341 | $37,547,000 | 18.51% |
| New Harbor Financial Group, LLC | 1,291,700 | $35,366,000 | 17.44% |
| MKP Capital Management, L.L.C. | 1,500,000 | $41,070,000 | 13.74% |
| Windmill Hill Asset Management Ltd | 844,600 | $23,125,000 | 11.94% |
| Hollow Brook Wealth Management LLC | 768,567 | $21,043,000 | 11.57% |
| Grand Central Investment Group | 261,915 | $7,171,000 | 10.33% |
| Point72 Europe (London) LLP | 1,467,000 | $40,166,000 | 8.50% |
| Slate Path Capital LP | 4,600,000 | $125,948,000 | 7.87% |